Literature DB >> 24321634

Respiratory impairment in cotton-ginning workers exposed to cotton dust.

Kamalesh J Dube1, Lalit T Ingale, Sopan T Ingle.   

Abstract

Dust generated during the handling and processing of cotton causes ill health of ginning workers. The purpose of this study was to determine the prevalence of respiratory symptoms among cotton-ginning workers. This study involved 188 workers of 10 cotton-ginning factories. Forced vital capacity (FVC), peak expiratory flow rate (PEFR), and forced expiratory volume in 1 s (FEV1) declined significantly with increasing duration of exposure (p < .001) of the cotton-ginning workers. Results of a standard respirator medical evaluation questionnaire indicated that, depending on duration of exposure, 51%-71% of cotton-ginning workers suffered from chest tightness, 55%-62% experienced chest pain, while 33%-42% of the workers reported frequent cough. Blood tests of the workers showed higher values of erythrocyte sedimentation rate, eosinophils, and white blood cells when exposure was longer. Byssinosis symptoms were observed among the workers. We recommend regular periodical medical check-ups, compulsory use of personal protective equipment, and proper ventilation at the workplace.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24321634     DOI: 10.1080/10803548.2013.11077009

Source DB:  PubMed          Journal:  Int J Occup Saf Ergon        ISSN: 1080-3548


  2 in total

1.  Reduced Cross-Shift Lung Function and Respiratory Symptoms among Integrated Textile Factory Workers in Ethiopia.

Authors:  Yifokire Tefera Zele; Abera Kumie; Wakgari Deressa; Bente E Moen; Magne Bråtveit
Journal:  Int J Environ Res Public Health       Date:  2020-04-16       Impact factor: 3.390

2.  Impact of using different predictive equations on the prevalence of chronic byssinosis in textile workers in Pakistan.

Authors:  Asaad Ahmed Nafees; Muhammad Zia Muneer; Sara De Matteis; Andre Amaral; Peter Burney; Paul Cullinan
Journal:  Occup Environ Med       Date:  2021-11-19       Impact factor: 4.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.